Cite
HARVARD Citation
Hallqvist, A. et al. (2018). Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial. Lung cancer. pp. 180-186. [Online].